OCSL — Oaktree Specialty Lending Corporation stock price, charts and financials
QT31Oaktree Specialty Lending CorporationOaktree Specialty Lending Corporation (NASDAQ: OCSL) is a Financial Services company in the Asset Management industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 21.28 | EPS (ttm) | 0.57 | Insider Own | 31.38% | Shs Outstand | 88.09M | Perf Week | 1.08% |
| Market Cap | 1.07B | Forward P/E | 8.84 | EPS next Y | 1.37 | Insider Trans | 0.02% | Shs Float | 87.69M | Perf Month | 0.83% |
| Enterprise Value | 2.50B | PEG | - | EPS next Q | - | Inst Own | - | Short Float | 4.18% | Perf Quarter | -5.97% |
| Income | 50.00M | P/S | 3.76 | EPS this Y | 162.33% | Inst Trans | - | Short Ratio | 5.05 | Perf Half Y | -0.90% |
| Sales | 284.00M | P/B | 0.77 | EPS next Y | -8.23% | ROA | 1.72% | Short Interest | 3.67M | Perf YTD | -4.79% |
| Book/sh | 15.69 | P/C | 20.95 | EPS next 5Y | -4.19% | ROE | 3.45% | 52W High | 14.31 -15.23% | Perf Year | -10.55% |
| Cash/sh | 0.58 | P/FCF | 81.68 | EPS past 3/5Y | -6.69% -14.02% | ROIC | 4.37% | 52W Low | 10.63 14.11% | Perf 3Y | -40.54% |
| Dividend Est. | 1.36 (11.21%) | EV/EBITDA | 19.38 | Sales past 3/5Y | 51.66% 30.59% | Gross Margin | 78.50% | Volatility | 2.27% 2.03% | Perf 5Y | -40.54% |
| Dividend TTM | 1.54 (12.70%) | EV/Sales | 8.80 | EPS Y/Y TTM | -20.83% | Oper. Margin | 45.24% | ATR (14) | 0.27 | Perf 10Y | -27.54% |
| Dividend Ex-Date | Jun 15, 2026 | Quick Ratio | 0.25 | Sales Y/Y TTM | 52.69% | Profit Margin | 17.43% | RSI (14) | 55.16 | Recom | 2.58 |
| Dividend Gr. 3/5Y | -11.58% 6.82% | Current Ratio | 0.25 | EPS Q/Q | -24.07% | SMA20 | 1.41% | Beta | 0.57 | Target Price | 12.50 |
| Payout | 272.91% | Debt/Eq | 1.01 | Sales Q/Q | 575.00% | SMA50 | 1.91% | Rel Volume | 0.83 | Prev Close | 11.94 |
| Employees | - | LT Debt/Eq | 1.01 | Earnings | Aug 05 | SMA200 | -2.15% | Avg Volume | 605.43K | Price | 12.13 |
| IPO Date | Jun 12, 2008 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 8.84% -0.36% | Net Debt/EBITDA | 11.41 | Volume | 501,929 | Change | 1.59% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| May-06-26 | Reiterated | Oppenheimer | Perform | $15 → $13 |
| Feb-05-26 | Reiterated | Wells Fargo | Equal Weight | $17 → $12 |
| Nov-20-24 | Downgrade | JP Morgan | Overweight → Neutral | |
| Nov-19-24 | Downgrade | JMP Securities | Market Outperform → Market Perform | |
| Aug-26-24 | Reiterated | Wells Fargo | Overweight | $17 |
| Aug-02-24 | Downgrade | Oppenheimer | Outperform → Perform | $18 |
| Feb-02-24 | Downgrade | Keefe, Bruyette & Woods | Outperform → Market Perform | |
| Jan-08-24 | Downgrade | B. Riley Securities | Buy → Neutral | |
| Jun-19-20 | Upgrade | Janney Capital | Neutral → Buy | |
| Jan-15-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Oaktree Specialty Lending Corporation (OCSL) functions as a business development company (BDC), dedicated to providing capital solutions for middle-market businesses. Its investment strategy involves a diverse array of financing types, including interim bridge loans, various tiers of secured debt (first and second lien, senior and junior), unsecured loans, hybrid mezzanine debt, and preferred equity stakes. These funds are primarily deployed to support growth initiatives such as corporate expansions, acquisitions led by private equity sponsors, and management buyouts within small and mid-sized enterprises. OCSL actively seeks opportunities across a broad spectrum of industries, including education, general business services, retail and consumer products, healthcare, manufacturing, the food and restaurant sector, construction and engineering, and media and advertising. Individual investments typically range from $5 million to $75 million, predominantly structured as integrated ("one-stop"), first-lien, or second-lien debt facilities, with the potential for a complementary equity co-investment. The target companies generally possess an enterprise value between $20 million and $150 million, and generate operating cash flow (EBITDA) of $3 million to $50 million. While the fund can commit up to $75 million per investment, it has the capacity to originate and underwrite larger transactions, up to $100 million. OCSL primarily concentrates its investment activities within the North American market and aims to serve as the lead investor in its portfolio companies.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 9/30/2025 | FY 2024 9/30/2024 | FY 2023 9/30/2023 | FY 2022 9/30/2022 | FY 2021 9/30/2021 | FY 2020 9/30/2020 | FY 2019 9/30/2019 | FY 2018 9/30/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 284 | 300 | 186 | 237 | 86 | 279 | 79 | 160 | 93 | |
| Cost of Goods Sold Incl. D&A | 61 | 38 | 129 | 112 | 47 | 31 | 26 | 32 | 36 | |
| Gross Profit | 223 | 261 | 58 | 125 | 39 | 248 | 52 | 127 | 57 | |
| Selling, General and Administrative Excl. Other | 7 | 8 | 10 | 12 | 9 | 9 | 7 | 8 | 11 | |
| Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other Operating Expense | 88 | 102 | -10 | -6 | -3 | -2 | 8 | -8 | -1 | |
| Operating Income | 129 | 151 | 58 | 119 | 33 | 241 | 37 | 127 | 47 | |
| Interest Expense | 110 | 116 | 129 | 112 | 47 | 31 | 26 | 32 | 36 | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 31 | 0 | 129 | 112 | 47 | 31 | 26 | 32 | 36 | |
| Net Income Before Taxes | 51 | 35 | 58 | 119 | 33 | 241 | 37 | 127 | 47 | |
| Income Taxes | 0 | 1 | 0 | 2 | 4 | 4 | -2 | 1 | 1 | |
| Consolidated Net Income | 50 | 34 | 58 | 117 | 29 | 237 | 39 | 126 | 47 | |
| Net Income From Continuing Operations | 50 | 34 | 58 | 117 | 29 | 237 | 39 | 126 | 47 | |
| Net Income | 50 | 34 | 58 | 117 | 29 | 237 | 39 | 126 | 47 | |
| EPS (Recurring) | 0.57 | 0.39 | 0.72 | 1.63 | 0.48 | 4.39 | 0.83 | 2.69 | 1.00 | |
| EPS (Basic, Before Extraordinaries) | 0.57 | 0.39 | 0.72 | 1.63 | 0.48 | 4.39 | 0.83 | 2.69 | 1.00 | |
| EPS (Diluted) | 0.57 | 0.39 | 0.72 | 1.63 | 0.48 | 4.39 | 0.83 | 2.69 | 1.00 | |
| EBITDA | 129 | 151 | 58 | 119 | 33 | 241 | 37 | 127 | 47 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 21.28 | 33.46 | 22.65 | 12.34 | 37.50 | 4.82 | 17.49 | 5.78 | 14.88 | |
| Price To Sales Ratio | 3.76 | 3.74 | 7.02 | 6.11 | 12.77 | 4.10 | 8.64 | 4.56 | 7.52 | |
| Gross Margin | 78.52 | 87.00 | 31.18 | 52.74 | 45.35 | 88.89 | 65.82 | 79.38 | 61.29 | |
| Operating Margin | 45.42 | 50.33 | 31.18 | 50.21 | 38.37 | 86.38 | 46.84 | 79.38 | 50.54 | |
| Net Margin | 17.61 | 11.33 | 31.18 | 49.37 | 33.72 | 84.95 | 49.37 | 78.75 | 50.54 | |
| Shares Outstanding | 88 | 86 | 80 | 72 | 61 | 54 | 47 | 47 | 47 | |
| Market Capitalization | 1,067 | 1,122 | 1,305 | 1,449 | 1,098 | 1,144 | 682 | 730 | 699 | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| CALDWELL PHYLLIS R | Director | Mar 16 '26 | Buy | 10.77 | 2,500 | 26,925 | 23,500 | Mar 18 |
| Gero Deborah Ann | Director | Mar 16 '26 | Buy | 10.78 | 2,000 | 21,558 | 24,411 | Mar 18 |
| CALDWELL PHYLLIS R | Director | Sep 15 '25 | Buy | 13.19 | 3,000 | 39,577 | 21,000 | Sep 16 |
| Gero Deborah Ann | Director | Jun 30 '25 | Buy | 13.70 | 2,500 | 34,250 | 22,411 | Jul 01 |
| Panossian Armen | See Remarks | May 15 '25 | Buy | 14.13 | 8,000 | 113,040 | 20,789 | May 19 |
| CALDWELL PHYLLIS R | Director | May 07 '25 | Buy | 13.32 | 2,000 | 26,650 | 18,000 | May 08 |
| Jacobson Craig A | Director | May 06 '25 | Buy | 13.41 | 14,910 | 199,919 | 71,667 | May 07 |
| CALDWELL PHYLLIS R | Director | Feb 25 '25 | Buy | 15.83 | 2,500 | 39,575 | 16,000 | Feb 26 |
| Pendo Mathew | President | Feb 24 '25 | Buy | 15.93 | 6,260 | 99,691 | 52,596 | Feb 25 |
| Khanna Raghav | Co-Chief Investment Officer | Feb 24 '25 | Buy | 15.95 | 6,000 | 95,700 | 6,000 | Feb 25 |
| CALDWELL PHYLLIS R | Director | Sep 20 '24 | Buy | 16.01 | 1,000 | 16,009 | 13,500 | Sep 23 |
| CALDWELL PHYLLIS R | Director | Aug 13 '24 | Buy | 16.29 | 1,334 | 21,726 | 12,500 | Aug 14 |
| CALDWELL PHYLLIS R | Director | Feb 12 '24 | Buy | 20.07 | 2,000 | 40,130 | 11,166 | Feb 14 |
| Pak Ashley | Chief Compliance Officer | Mar 09 '23 | Buy | 19.41 | 1,000 | 19,405 | 1,920 | Apr 12 |
| Stewart Matthew | Chief Operating Officer | Mar 23 '23 | Buy | 18.00 | 500 | 9,000 | 9,668 | Mar 27 |